232 related articles for article (PubMed ID: 31560977)
1. Pyoderma gangrenosum in hematologic malignancies: A systematic review.
Montagnon CM; Fracica EA; Patel AA; Camilleri MJ; Murad MH; Dingli D; Wetter DA; Tolkachjov SN
J Am Acad Dermatol; 2020 Jun; 82(6):1346-1359. PubMed ID: 31560977
[TBL] [Abstract][Full Text] [Related]
2. The dilemma of treating pyoderma gangrenosum associated with monoclonal gammopathy of undetermined significance.
Machan A; Azendour H; Frikh R; Hjira N; Boui M
Dermatol Online J; 2020 May; 26(5):. PubMed ID: 32621712
[TBL] [Abstract][Full Text] [Related]
3. Pyoderma gangrenosum, erythema elevatum diutinum and IgA monoclonal gammopathy.
Wayte JA; Rogers S; Powell FC
Australas J Dermatol; 1995 Feb; 36(1):21-3. PubMed ID: 7763217
[TBL] [Abstract][Full Text] [Related]
4. Bullous pyoderma gangrenosum as the presenting sign of fatal acute myelogenous leukemia.
Fox LP; Geyer AS; Husain S; Grossman ME
Leuk Lymphoma; 2006 Jan; 47(1):147-50. PubMed ID: 16321840
[TBL] [Abstract][Full Text] [Related]
5. Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients.
Vacas AS; Torre AC; Bollea-Garlatti ML; Warley F; Galimberti RL
Int J Dermatol; 2017 Apr; 56(4):386-391. PubMed ID: 28295267
[TBL] [Abstract][Full Text] [Related]
6. [Pyoderma gangrenosum and hemopathies in older patients].
Gay P; Villain C; Kottler D; Rouet A; Tomeo C; Baron M; Choquet S; Barete S; Minaud A; Barrou Z; Verny M
Geriatr Psychol Neuropsychiatr Vieil; 2023 Mar; 21(1):31-36. PubMed ID: 37115677
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal gammopathy in the setting of Pyoderma gangrenosum.
Saeidi V; Garimella V; Shaji K; Wetter DA; Davis MDP; Todd A; Dutz J; Alavi A
Arch Dermatol Res; 2024 May; 316(6):268. PubMed ID: 38795175
[TBL] [Abstract][Full Text] [Related]
8. Clonality in the setting of Sweet's syndrome and pyoderma gangrenosum is not limited to underlying myeloproliferative disease.
Magro CM; Kiani B; Li J; Crowson AN
J Cutan Pathol; 2007 Jul; 34(7):526-34. PubMed ID: 17576331
[TBL] [Abstract][Full Text] [Related]
9. Myeloid sarcoma developing in pre-existing pyoderma gangrenosum.
Kristensen IB; Møller H; Kjaerskov MW; Yderstraede K; Møller MB; Bergmann OJ
Acta Derm Venereol; 2009; 89(2):175-7. PubMed ID: 19326005
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory arthritis-associated pyoderma gangrenosum: a systematic review.
Sawka E; Zhou A; Latour E; Friedman M; Ortega-Loayza AG
Clin Rheumatol; 2021 Oct; 40(10):3963-3969. PubMed ID: 34002351
[TBL] [Abstract][Full Text] [Related]
11. Ulceration associated with stable myelodysplastic syndrome: atypical pyoderma gangrenosum?
Harris A; O'hea AM; Burge S
Clin Exp Dermatol; 1998 Nov; 23(6):293-5. PubMed ID: 10233632
[No Abstract] [Full Text] [Related]
12. The pseudo-Pelger-Huët anomaly in pyoderma gangrenosum associated with myelodysplastic syndrome.
Chiang M; Fleming M
Am J Dermatopathol; 2007 Jun; 29(3):293-5. PubMed ID: 17519630
[TBL] [Abstract][Full Text] [Related]
13. Pyoderma gangrenosum complicated with myelodysplastic syndrome followed by rapidly progressing pyothorax-associated lymphoma: a case report.
Goto A; Yamamoto S; Notoya A; Takada A; Mukai M
Hokkaido Igaku Zasshi; 2006 Jul; 81(4):261-4. PubMed ID: 16892654
[TBL] [Abstract][Full Text] [Related]
14. Delayed diagnosis of bullous pyoderma gangrenosum with acute myelogenous leukemia.
Sener S; Sarac G; Altunisik N; Bayindir Y
Niger J Clin Pract; 2016; 19(6):837-839. PubMed ID: 27811462
[TBL] [Abstract][Full Text] [Related]
15. Pyoderma gangrenosum associated with biphenotypic acute leukemia.
Asai M; Aragane Y; Kawada A; Shimada T; Kanamaru A; Yamada H; Tezukam T
J Am Acad Dermatol; 2001 Mar; 44(3):530-1. PubMed ID: 11209130
[TBL] [Abstract][Full Text] [Related]
16. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
17. Bullous pyoderma gangrenosum as a predictor of hematological malignancies.
Vacas AS; Bollea-Garlatti ML; Torre AC; Galimberti RL
An Bras Dermatol; 2018; 93(1):133-134. PubMed ID: 29641716
[TBL] [Abstract][Full Text] [Related]
18. Pyoderma gangrenosum complicated with hematological malignancies: Two case reports.
Li F; Zhao J; Duan H; Zhang H; Zhang L; Zhao L; Wen Y; Gu X
Medicine (Baltimore); 2024 Mar; 103(10):e37159. PubMed ID: 38457569
[TBL] [Abstract][Full Text] [Related]
19. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions.
Bennett ML; Jackson JM; Jorizzo JL; Fleischer AB; White WL; Callen JP
Medicine (Baltimore); 2000 Jan; 79(1):37-46. PubMed ID: 10670408
[TBL] [Abstract][Full Text] [Related]
20. The Association of Age With Clinical Presentation and Comorbidities of Pyoderma Gangrenosum.
Ashchyan HJ; Butler DC; Nelson CA; Noe MH; Tsiaras WG; Lockwood SJ; James WD; Micheletti RG; Rosenbach M; Mostaghimi A
JAMA Dermatol; 2018 Apr; 154(4):409-413. PubMed ID: 29450453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
